Analysis of Vascular Closure Devices After Transbrachial Artery Access

Mirza, Aleem K.; Steerman, Samuel; Ahanchi, Sadaf S.; Higgins, Jonathan A.; Mushti, Sirisha; Panneton, Jean M.

doi:10.1177/1538574414551576

Cited by 21 publications

(16 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[15][16][17][18] Currently, no VCDs are indicated for use in the BA; however, early reports from studies that have reviewed off-label use of VCDs in the BA indicate they are likely safe. 19,20 Further studies evaluating the use and safety of VCDs in BA access should be completed.…”

Section: Discussionmentioning

confidence: 99%

Treatment of peripheral arterial disease via percutaneous brachial artery access

Franz

Tanga

Herrmann

2017

Journal of Vascular Surgery

View full text Add to dashboard Cite

Brachial access is a reliable and effective option for treatment of peripheral vascular disease and should be considered when femoral access is difficult or contraindicated and when a bypass graft is present in the femoral region. In addition, bilateral lesions may be approached easily through one brachial artery access site, making this approach advantageous when bilateral lesions are expected. The complication rate is similar to femoral access and can be minimized with ultrasound-guided access distally over the humerus, micropuncture access, and a dedicated postprocedure "hold team."

show abstract

Section: Discussionmentioning

confidence: 99%

Treatment of peripheral arterial disease via percutaneous brachial artery access

Franz

Tanga

Herrmann

2017

Journal of Vascular Surgery

View full text Add to dashboard Cite

show abstract

“…The results showed that AVCD was successfully deployed in 36 patients, and hemostasis was achieved within several minutes. Lupattelli et al 14 applied AVCDs in 79 patients, and the success rate for achieving 13,18 Although there are no specific devices designed for the closure of transbrachial procedures, these attempts have proved that it is feasible to use the occlusion device for hemostasis at the brachial artery puncture site. EVCD has been originally designed for closure of femoral puncture sites and has been widely used in clinical vascular closure procedures for longer periods.…”

Section: Discussionmentioning

confidence: 99%

A Retrospective Study Comparing the Effectiveness and Safety of EXOSEAL Vascular Closure Device to Manual Compression in Patients Undergoing Percutaneous Transbrachial Procedures

Wei

Han

Sun

et al. 2020

Annals of Vascular Surgery

View full text Add to dashboard Cite

Background: This study aimed to assess the safety and efficacy of EXOSEAL vascular closure device (EVCD) insertion by comparing its performance with manual compression (MC) in achieving hemostasis at the brachial artery puncture site. Methods: A retrospective study of brachial artery access by using either MC or EVCD for achieving hemostasis from March 2016 to October 2017 was conducted. Patients with Stanford type B aortic dissection (TBAD) undergoing percutaneous transbrachial procedures were included. Time to hemostasis (TTH) was the primary efficacy end point. Seven-day incidence of major access siteerelated complications was the primary safety end point. TTH and major and minor complications associated with treatment of these 2 groups were also evaluated. Results: A total of 157 patients with TBAD undergoing percutaneous transbrachial procedures entered the analysis. Of these, 107 patients underwent EVCD insertion and 50 patients underwent MC. The baseline characteristics of the 2 groups were similar. TTH was significantly shorter for EVCD over MC (P < 0.05). The TTH 10 min in the MC group was 100.0% (n ¼ 50), but in the EVCD group, it was 2 min, 87.9% (n ¼ 107); 2e5 min, 7.5% (n ¼ 107); and 10 min, 4.7% (n ¼ 107). The EVCD group had several major complications, while the MC group had none. Two patients (1.9%, n ¼ 107) required vascular repair, one patient (0.6%, n ¼ 107) required blood transfusion, and 1 patient (0.6%, n ¼ 107) developed upper limb numbness and weakness after EVCD deployment. Minor complication such as the occurrence of hematoma (5 cm) in the MC group was 4 (8.0%) but was also 4 (3.7%) in the EVCD group, showing statistically significant difference (P ¼ 0.030). The incidence of ecchymosis was Xiaolong Wei, Tonglei Han and Yudong Sun contributed equally to this work.

show abstract

“…Arteriotomy closure devices represent an interesting alternative to manual compression after brachial artery access. 7 Although a good front wall puncture is a key prerequisite and a meticulous technique is paramount, favorable results have already been reported for several devices, including the AngioSeal, 8 Boomerang, 9 , 10 Perclose, 11 and StarClose, 10 , 12 among others.…”

Section: Discussionmentioning

confidence: 99%

Hemostasis After Brachial Artery Access With the MynxGrip Device: A Case Report

Giordano

Messina

Maresca

et al. 2018

Clin Med Insights Cardiol

View full text Add to dashboard Cite

Purpose:Brachial access is occasionally used for endovascular procedures when other more established or safer ones (eg, femoral or radial) are contraindicated. Although manual compression is the standard of care after brachial arteriotomy, suboptimal compression may lead to bleeding or thrombosis. Arteriotomy closure devices have thus been proposed as an alternative means to achieve hemostasis after brachial arteriotomy. Yet, there is a paucity of evidence and a limited spectrum of devices suitable for brachial arteriotomy closure. We present the use of the MynxGrip closure device after brachial arteriotomy.Case:A 70-year-old gentleman underwent brachial arteriotomy followed by iliac artery stenting with a 7F compatible device. Hemostasis was then achieved with the MynxGrip device, uneventfully.Conclusions:This clinical vignette highlights the feasibility and safety of brachial use of the MynxGrip device in experienced hands, suggesting that it can represent a useful adjunct to the armamentarium of the endovascular specialist.

show abstract

Analysis of Vascular Closure Devices After Transbrachial Artery Access

Abstract: Use of VCD in the brachial artery following an endovascular procedure showed equivalence to MC.

Cited by 21 publications

References 8 publications

Treatment of peripheral arterial disease via percutaneous brachial artery access

Treatment of peripheral arterial disease via percutaneous brachial artery access

A Retrospective Study Comparing the Effectiveness and Safety of EXOSEAL Vascular Closure Device to Manual Compression in Patients Undergoing Percutaneous Transbrachial Procedures

Hemostasis After Brachial Artery Access With the MynxGrip Device: A Case Report

Contact Info

Product

Resources

About